Literature DB >> 25753471

Increased cortical synaptic activation of TrkB and downstream signaling markers in a mouse model of Down Syndrome.

R L Nosheny1, P V Belichenko2, B L Busse3, A M Weissmiller2, V Dang4, D Das4, A Fahimi4, A Salehi4, S J Smith3, W C Mobley2.   

Abstract

Down Syndrome (DS), trisomy 21, is characterized by synaptic abnormalities and cognitive deficits throughout the lifespan and with development of Alzheimer's disease (AD) neuropathology and progressive cognitive decline in adults. Synaptic abnormalities are also present in the Ts65Dn mouse model of DS, but which synapses are affected and the mechanisms underlying synaptic dysfunction are unknown. Here we show marked increases in the levels and activation status of TrkB and associated signaling proteins in cortical synapses in Ts65Dn mice. Proteomic analysis at the single synapse level of resolution using array tomography (AT) uncovered increased colocalization of activated TrkB with signaling endosome related proteins, and demonstrated increased TrkB signaling. The extent of increases in TrkB signaling differed in each of the cortical layers examined and with respect to the type of synapse, with the most marked increases seen in inhibitory synapses. These findings are evidence of markedly abnormal TrkB-mediated signaling in synapses. They raise the possibility that dysregulated TrkB signaling contributes to synaptic dysfunction and cognitive deficits in DS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BDNF; Cerebral cortex; Down Syndrome; Signaling endosomes; Synapses; TrkB; Ts65Dn mice

Mesh:

Substances:

Year:  2015        PMID: 25753471      PMCID: PMC4689307          DOI: 10.1016/j.nbd.2015.02.022

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  68 in total

1.  Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration.

Authors:  Ahmad Salehi; Jean-Dominique Delcroix; Pavel V Belichenko; Ke Zhan; Chengbiao Wu; Janice S Valletta; Ryoko Takimoto-Kimura; Alexander M Kleschevnikov; Kumar Sambamurti; Peter P Chung; Weiming Xia; Angela Villar; William A Campbell; Laura Shapiro Kulnane; Ralph A Nixon; Bruce T Lamb; Charles J Epstein; Gorazd B Stokin; Lawrence S B Goldstein; William C Mobley
Journal:  Neuron       Date:  2006-07-06       Impact factor: 17.173

2.  Efferent and afferent connections of mouse sensory-motor cortex following cholinergic deafferentation at birth.

Authors:  C F Höhmann; L Wilson; J T Coyle
Journal:  Cereb Cortex       Date:  1991 Mar-Apr       Impact factor: 5.357

3.  Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus.

Authors:  Henri Autio; Kert Mätlik; Tomi Rantamäki; Lothar Lindemann; Marius C Hoener; Moses Chao; Urmas Arumäe; Eero Castrén
Journal:  Neuropharmacology       Date:  2011-07-30       Impact factor: 5.250

4.  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

Authors:  A M Cataldo; J L Barnett; C Pieroni; R A Nixon
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

5.  Effect of 7,8-dihydroxyflavone, a small-molecule TrkB agonist, on emotional learning.

Authors:  Raul Andero; Scott A Heldt; Keqiang Ye; Xia Liu; Antonio Armario; Kerry J Ressler
Journal:  Am J Psychiatry       Date:  2010-12-01       Impact factor: 18.112

6.  Endocytosis of activated TrkA: evidence that nerve growth factor induces formation of signaling endosomes.

Authors:  M L Grimes; J Zhou; E C Beattie; E C Yuen; D E Hall; J S Valletta; K S Topp; J H LaVail; N W Bunnett; W C Mobley
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

7.  Failure of brain-derived neurotrophic factor-dependent neuron survival in mouse trisomy 16.

Authors:  Susan G Dorsey; Linda L Bambrick; Rita J Balice-Gordon; Bruce K Krueger
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

8.  App gene dosage modulates endosomal abnormalities of Alzheimer's disease in a segmental trisomy 16 mouse model of down syndrome.

Authors:  Anne M Cataldo; Suzana Petanceska; Corrinne M Peterhoff; Nicole B Terio; Charles J Epstein; Angela Villar; Elaine J Carlson; Matthias Staufenbiel; Ralph A Nixon
Journal:  J Neurosci       Date:  2003-07-30       Impact factor: 6.167

9.  Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus.

Authors:  H Kang; E M Schuman
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

10.  Rab5 and Rab7 control endocytic sorting along the axonal retrograde transport pathway.

Authors:  Katrin Deinhardt; Sara Salinas; Carole Verastegui; Rose Watson; Daniel Worth; Sarah Hanrahan; Cecilia Bucci; Giampietro Schiavo
Journal:  Neuron       Date:  2006-10-19       Impact factor: 17.173

View more
  7 in total

Review 1.  Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome.

Authors:  Xu-Qiao Chen; Mariko Sawa; William C Mobley
Journal:  Free Radic Biol Med       Date:  2017-10-12       Impact factor: 7.376

2.  Amyloid precursor protein-mediated endocytic pathway disruption induces axonal dysfunction and neurodegeneration.

Authors:  Wei Xu; April M Weissmiller; Joseph A White; Fang Fang; Xinyi Wang; Yiwen Wu; Matthew L Pearn; Xiaobei Zhao; Mariko Sawa; Shengdi Chen; Shermali Gunawardena; Jianqing Ding; William C Mobley; Chengbiao Wu
Journal:  J Clin Invest       Date:  2016-04-11       Impact factor: 14.808

3.  Aerobic exercise and a BDNF-mimetic therapy rescue learning and memory in a mouse model of Down syndrome.

Authors:  Martina Parrini; Diego Ghezzi; Gabriele Deidda; Lucian Medrihan; Enrico Castroflorio; Micol Alberti; Pietro Baldelli; Laura Cancedda; Andrea Contestabile
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

Review 4.  Intellectual disability: dendritic anomalies and emerging genetic perspectives.

Authors:  Tam T Quach; Harrison J Stratton; Rajesh Khanna; Pappachan E Kolattukudy; Jérome Honnorat; Kathrin Meyer; Anne-Marie Duchemin
Journal:  Acta Neuropathol       Date:  2020-11-23       Impact factor: 17.088

5.  Synaptic Vesicle Recycling Is Unaffected in the Ts65Dn Mouse Model of Down Syndrome.

Authors:  Jamie R K Marland; Karen J Smillie; Michael A Cousin
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

6.  Q&A: Array tomography.

Authors:  Stephen J Smith
Journal:  BMC Biol       Date:  2018-09-06       Impact factor: 7.431

7.  Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.

Authors:  Xu-Qiao Chen; Ahmad Salehi; Matthew L Pearn; Cassia Overk; Phuong D Nguyen; Alexander M Kleschevnikov; Maria Maccecchini; William C Mobley
Journal:  Alzheimers Dement       Date:  2020-09-25       Impact factor: 21.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.